Next was the expansion and refresh of the space, the final push of which happened in late August during a brief shutter. The most obvious change included cutting through the wall and adding a ...

Stock gains 4% after USFDA final approval for Dapagliflozin 5mg and 10mg, generic of AstraZeneca's Farxiga worth $10.4bn ...

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Dapagliflozin ...

“Even if tariffs do come in at 5-10 percent, they can be absorbed. But anything above 25 percent could make high-volume, low-margin products unviable,” said Pranav Amin, Managing Director, Alembic ...

Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration (USFDA) for ...

Shares of Alembic Pharmaceuticals Ltd surged 13.61 per cent in Monday's trade, touching a high of Rs 1,104.10, following a key regulatory milestone. The rally came after the company received final ...

Alembic Pharma receives US FDA final approval for dapagliflozin tablets, 5 mg and 10 mg: Our Bureau, Mumbai Tuesday, April 7, 2026, 14:30 Hrs [IST] Alembic Pharmaceuticals Limited ...

SAN FRANCISCO--(BUSINESS WIRE)--Alembic, the leading holistic marketing attribution platform for enterprises, today announced it received $14 million in series A funding. The round was led by WndrCo, ...

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in ...

Check Alembic Stock Price live NSE/BSE on financialexpress.com. Get Alembic today's stock price, 52-week high, 52-week low, Alembic quarterly results, share performance, financials, peer comparison, ...